Researchers from The University of Texas MD Anderson Cancer Center found the KRAS G12C inhibitor adagrasib showed promising activity suppressing cancer growth not only within the lungs but also in brain metastases for patients ...
Jun 16, 2023
0
28
Researchers at Children's Hospital of Philadelphia (CHOP) have identified a molecule that plays a role in post-translational modification and activation in myeloid malignancies, making it a potential therapeutic target. The ...
Jun 16, 2023
0
11
A new research perspective was published in Oncotarget, titled "Targeting the Src N-terminal regulatory element in cancer."
Jun 9, 2023
0
7
A gene regulating the F-Box and WD Repeat Domain Containing 7 (FBXW7) protein is frequently mutated or deleted in various types of human cancer, including gynecological cancers. Such FBXW7 mutations have been associated with ...
May 18, 2023
0
37
A new research paper was published in Oncotarget, titled, "Human LY6 gene family: potential tumor-associated antigens and biomarkers of prognosis in uterine corpus endometrial carcinoma."
May 8, 2023
0
28
The location where cancer patients spend their last days can affect their "quality of death." However, it remains unclear whether the location along with the received treatment and care can affect their survival. Therefore, ...
May 8, 2023
0
2
In patients with chronic limb threatening ischemia (CLTI) due to atherosclerosis affecting the arteries below the knee, data from the first clinical trial of its kind shows that a best endovascular treatment first revascularization ...
May 2, 2023
0
22
A long-term analysis designed by Christian Gerges and Irene Lang at the Department of Medicine II of the University Hospital Vienna and MedUni Vienna indicates that one third of patients with chronic thromboembolic pulmonary ...
Apr 27, 2023
0
2
For patients with multiple myeloma (MM), there has been an improvement in prognosis since 2000, but mortality still remains elevated, according to a study published online April 6 in BMC Cancer.
Apr 25, 2023
0
17
Scientists at St. Jude Children's Research Hospital developed a novel combination therapy approach for a leukemia subtype harboring rearrangements in the KMT2A gene. The approach overcomes the cancer's drug resistance, without ...
Apr 11, 2023
0
24
